Xinxin Ding
- Head, Pharmacology and Toxicology
- Professor, Pharmacology and Toxicology
- Professor, BIO5 Institute
- Member of the Graduate Faculty
- Professor, Cancer Biology - GIDP
- Professorship, R Ken and Donna Coit
Contact
- (520) 626-9906
- Pharmacy, Rm. 345G
- Tucson, AZ 85721
- xding@arizona.edu
Bio
No activities entered.
Interests
No activities entered.
Courses
2024-25 Courses
-
Drug Metabolism + Dsptn
CBIO 550 (Spring 2025) -
Drug Metabolism + Dsptn
PCOL 550 (Spring 2025) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2025) -
Contemp Topics Drug Discovery
CBIO 530 (Fall 2024) -
Contemp Topics Drug Discovery
PCOL 530 (Fall 2024) -
Contemp Topics Drug Discovery
PHSC 530 (Fall 2024) -
Directed Research
PCOL 792 (Fall 2024) -
Dissertation
PCOL 920 (Fall 2024) -
General+Systems Tox
PCOL 535 (Fall 2024) -
Introduction to Pharmacology
PCOL 501 (Fall 2024) -
Introduction to Pharmacology
PHSC 501 (Fall 2024) -
Leadership in Pharmacy
PHPR 833 (Fall 2024)
2023-24 Courses
-
Dissertation
PCOL 920 (Spring 2024) -
Drug Metabolism + Dsptn
PCOL 550 (Spring 2024) -
Honors Thesis
PCOL 498H (Spring 2024) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2024) -
Research Conference
PCOL 695A (Spring 2024) -
Dissertation
PCOL 920 (Fall 2023) -
General+Systems Tox
CBIO 535 (Fall 2023) -
General+Systems Tox
PCOL 535 (Fall 2023) -
Honors Thesis
PCOL 498H (Fall 2023) -
Introduction to Pharmacology
PCOL 501 (Fall 2023) -
Research
BIOC 900 (Fall 2023) -
Research Conference
PCOL 695A (Fall 2023)
2022-23 Courses
-
Directed Research
MCB 792 (Spring 2023) -
Dissertation
PCOL 920 (Spring 2023) -
Drug Metabolism + Dsptn
PCOL 550 (Spring 2023) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2023) -
Research
PCOL 900 (Spring 2023) -
Research Conference
PCOL 695A (Spring 2023) -
Dissertation
PCOL 920 (Fall 2022) -
General+Systems Tox
CBIO 535 (Fall 2022) -
General+Systems Tox
PCOL 535 (Fall 2022) -
Independent Study
PCOL 399 (Fall 2022) -
Introduction to Pharmacology
PCOL 501 (Fall 2022) -
Introduction to Pharmacology
PHSC 501 (Fall 2022) -
PharmTox Journal Club
PCOL 595A (Fall 2022) -
Research
PCOL 900 (Fall 2022) -
Research Conference
PCOL 695A (Fall 2022)
2021-22 Courses
-
Dissertation
PCOL 920 (Spring 2022) -
Drug Metabolism + Dsptn
CBIO 550 (Spring 2022) -
Drug Metabolism + Dsptn
PCOL 550 (Spring 2022) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2022) -
Research
PCOL 900 (Spring 2022) -
Research Conference
PCOL 695A (Spring 2022) -
Dissertation
PCOL 920 (Fall 2021) -
General+Systems Tox
PCOL 535 (Fall 2021) -
Introduction to Pharmacology
PCOL 501 (Fall 2021) -
Introduction to Pharmacology
PHSC 501 (Fall 2021) -
Research
PCOL 900 (Fall 2021) -
Research Conference
PCOL 695A (Fall 2021)
2020-21 Courses
-
Drug Dsptn+Metabolism
CBIO 550 (Spring 2021) -
Drug Dsptn+Metabolism
PCOL 550 (Spring 2021) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2021) -
Research
PCOL 900 (Spring 2021) -
Research Conference
PCOL 695A (Spring 2021) -
Clinical Pathophysiology I
PCOL 838A (Fall 2020) -
Directed Research
MCB 792 (Fall 2020) -
Intro Molecular Therapeutics
CBIO 530 (Fall 2020) -
Intro Molecular Therapeutics
CHEM 530 (Fall 2020) -
Intro Molecular Therapeutics
PCOL 530 (Fall 2020) -
Intro Molecular Therapeutics
PHSC 530 (Fall 2020) -
Introduction to Pharmacology
PCOL 501 (Fall 2020) -
Introduction to Pharmacology
PHSC 501 (Fall 2020) -
Research
PCOL 900 (Fall 2020) -
Research Conference
PCOL 695A (Fall 2020)
2019-20 Courses
-
Drug Dsptn+Metabolism
PCOL 550 (Spring 2020) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2020) -
Research
PCOL 900 (Spring 2020) -
Research Conference
PCOL 695A (Spring 2020) -
Clinical Pathophysiology I
PCOL 838A (Fall 2019) -
Honors Independent Study
PCOL 499H (Fall 2019) -
Introduction to Research
MCB 795A (Fall 2019) -
Research Conference
PCOL 695A (Fall 2019)
2018-19 Courses
-
Dissertation
PHSC 920 (Spring 2019) -
Drug Dsptn+Metabolism
CBIO 550 (Spring 2019) -
Drug Dsptn+Metabolism
PCOL 550 (Spring 2019) -
Intro to Pharmacology/MedChem
PCOL 824 (Spring 2019) -
Clinical Pathophysiology I
PCOL 838A (Fall 2018) -
Introduction to Research
MCB 795A (Fall 2018) -
Pharmacology I
PCOL 571A (Fall 2018) -
Pharmacology I
PCOL 871A (Fall 2018)
2017-18 Courses
-
Drug Dsptn+Metabolism
CBIO 550 (Spring 2018) -
Drug Dsptn+Metabolism
PCOL 550 (Spring 2018)
Scholarly Contributions
Journals/Publications
- Buchholz, B. A., Carratt, S. A., Kuhn, E. A., Collette, N. M., Ding, X., & Van, W. (2019). Naphthalene DNA adduct formation and tolerance in the lung. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 438, 119-123.
- Carratt, S. A., Hartog, M., Buchholz, B. A., Kuhn, E. A., Collette, N. M., Ding, X., & Van, W. (2019). Naphthalene genotoxicity: DNA adducts in primate and mouse airway explants. TOXICOLOGY LETTERS, 305, 103-109.
- Carratt, S. A., Kovalchuk, N., Ding, X., & Van, W. (2019). Metabolism and Lung Toxicity of Inhaled Naphthalene: Effects of Postnatal Age and Sex. TOXICOLOGICAL SCIENCES, 170(2), 536-548.
- Fan, X., Li, H., Ding, X., & Zhang, Q. (2019). Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, a Repurposed Drug with Poor Bioavailability. DRUG METABOLISM AND DISPOSITION, 47(7), 756-763.
- Hartog, M., Zhang, Q., & Ding, X. (2019). Role of Mouse Cytochrome P450 Enzymes of the Cyp2abfgs Subfamilies in the Induction of Lung Inflammation by Cigarette Smoke Exposure. TOXICOLOGICAL SCIENCES, 172(1), 123-131.
- Kovalchuk, N., Zhang, Q., Kelty, J., Van, W. L., & Ding, X. (2019). Toxicokinetic Interaction between Hepatic Disposition and Pulmonary Bioactivation of Inhaled Naphthalene Studied Using Cyp2abfgs-Null and CYP2A13/2F1-Humanized Mice with Deficient Hepatic Cytochrome P450 Activity. DRUG METABOLISM AND DISPOSITION, 47(12), 1469-1478.
- Wang, H., Qin, M., Liu, R., Ding, X., Chen, I., & Jiang, Y. (2019). Characterization of A Bifunctional Synthetic RNA Aptamer and A Truncated Form for Ability to Inhibit Growth of Non-Small Cell Lung Cancer. SCIENTIFIC REPORTS, 9.
- Zhang, Y. u., Shen, B., Guan, X., Qin, M., Ren, Z., Ma, Y., Dai, W., Ding, X., & Jiang, Y. (2019). Safety and efficacy of ex vivo expanded CD34(+) stem cells in murine and primate models. STEM CELL RESEARCH & THERAPY, 10.